Latest News

The dominant sportwear maker continues to struggle as it aims to turn the business around.

Monte Rosa Therapeutics (NASDAQ:GLUE) reported results from GFORCE-1, a Phase I study of its NEK7-directed molecular glue degrader MRT-8102 in participants with elevated cardiovascular risk. The company said the four-week dosing study showed sustained degradation of NEK7, reductions in inflammatory

Most of the decade's rise came this year. What would it take to do it all over?

Both pure plays just received additional government funding and have a few customers.

This under-the-radar fintech stock boasts a Superscore of 74 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

Ten years of beating the S&P 500 is tough to ignore -- but is it a reason to buy at a record?

Taiwan Semiconductor supplies nearly every competitor in the AI arena with chips.

The chip fund needs gains of around 14% a year to get there. What might stop it?

SKYX Platforms (NASDAQ:SKYX) Chief Executive Officer Lenny Sokolow outlined the company’s product strategy, planned merger with smart-home device provider Deako, and expansion efforts during Noble Capital Markets’ Virtual Equity Conference. Sokolow said SKYX is focused on plug-and-play electrical p

Kaltura (NASDAQ:KLTR) outlined its strategy to expand beyond enterprise video software into AI-driven conversational and personalized digital experiences during a presentation hosted by Noble Capital Markets. Ron Yekutiel, Kaltura’s president and CEO, said the company has operated for 20 years as a

The contrarian investor has bought the stock several times this year.

This business has been a portfolio winner, but the income stream it generates isn't turning any heads.

Soaring long-term yields aren't necessarily a bad thing for the S&P 500.

Nvidia is priced cheaply from a forward earnings standpoint.

Vince (NASDAQ:VNCE) CEO Brendan Hoffman said the apparel company’s recent double-digit second-quarter revenue growth was driven by continued product improvements and demand across both direct-to-consumer and wholesale channels, while CFO Yuji Okumura pointed to lower debt and potential operating lev

Digital infrastructure provider Applied Digital (NASDAQ:APLD) will be reporting earnings this Wednesday afternoon. Here’s what investors should know. Applied...

Electronics distributor Richardson Electronics (NASDAQ:RELL) will be announcing earnings results this Wednesday after the bell. Here’s what to expect. Richar...

Denim clothing company Levi's (NYSE:LEVI) will be reporting earnings this Wednesday after market hours. Here’s what investors should know. Levi's beat analys...

Higher interest rates squeeze margins, and automation helps reduce costs.

Vaxcyte (NASDAQ:PCVX) said its investigational 31-valent pneumococcal conjugate vaccine, VAX-31, met all pre-specified primary immunogenicity endpoints in the pivotal Phase III OPUS-1 trial in adults. The randomized, double-blind, active-controlled study enrolled 4,047 U.S. adults, including 3,572

Both companies burn cash heavily while chasing commercialization, but their business models and risk profiles diverge sharply.

(Photo: Game Play Entertainment Fun Relax Leisure Graphic | Shutterstock)Digital products compete for more than downloads or sign-ups. They also compete fo

Nvidia's 55.6% net margin and $96.7B free cash flow dwarf Taiwan Semi's, but geopolitical risks and customer concentration pose distinct threats to each.

Pedevco (NYSEAMERICAN:PED) outlined plans to accelerate development across its Rocky Mountain oil and gas portfolio while pursuing selective acquisitions, as Interim President, Chief Executive Officer and Chief Operating Officer R.T. Dukes said the company has strengthened its balance sheet and is p